Applied Biosystems/U.S. Department of Defense Terminate Contract for Prototype Instrument System to Identify Infectious Diseases
Parties Could Not Agree on Further Development and Commercialization
Applied Biosystems, an Applera Corporation business, announced that its contract with the U.S. Department of Defense surrounding the development of a prototype instrument system to improve the way infectious diseases are identified for epidemiological and biosecurity purposes has been terminated for the convenience of the government. Though Applied Biosystems had successfully completed all technical milestones required to date in the contract, the action was taken by the government after Applied Biosystems and the U.S. Air Force were unable to agree on an approach for further development and commercialization of an instrument system that could be derived from an AB prototype instrument. Applied Biosystems anticipates no material financial impact from the contract termination.
Applied Biosystems expects that its biosecurity strategy will continue to focus on delivering early warning systems for detecting and tracking emerging natural and man-made pathogens in the environment, in agriculture, and in the animal and human food supply.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
UMC Utrecht and VectorY Therapeutics collaborate in ALS Biomarker Study - Finding these biomarkers is expected to help diagnose ALS and monitor disease progression and improve the design of future clinical studie
Diatom ooze sediments are a large marine mercury sink - Sediments reveal mercury pollution in Antarctica since the beginning of the industrial period
Henry Ford's idea revisited in DNA copying
First view of hydrogen at the metal-to-metal hydride interface
Waters Corporation to Assist US EPA in the Analysis of Perfluorinated Compounds (PFCs) in Soil and Water - Latest CRADA Aimed at Developing Liquid Chromatography and Mass Spectrometry Methods for Measuring PFCs at Very Low Concentrations
ZEISS: High-Tech Drives Growth - Medical technology and industrial metrology business still on track for growth
Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games
Grace extends reach in China
Mapping nanoscale chemical reactions inside batteries in 3-D
Virtual human in HIV drug simulation
No excess baggage: Antarctic insect's genome, newly sequenced, is smallest to date - Researchers suggest bare-bones genome is adaptation to deep freeze